Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

News > All

Total search results: 7103 | Ordered by Date (descending)
1 2 3 ... 70 71 72  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Ablynx N.V.. (10/17/17). "Press Release: Ablynx Announces Launch of Proposed Global Offering". Ghent. 2017-10-17
Bryan, Garnier & Co., Ltd.. (10/17/17). "Press Release: Bryan, Garnier & Co Strengthens Its Investment Banking Team with the Hiring of Marc-Antoine Janny as Vice President". Paris. 2017-10-17
Ablynx N.V.. (10/16/17). "Press Release: Ablynx Establishes Subsidiary in the USA and Appoints a General Manager". Ghent. 2017-10-16
Apeiron Biologics AG. (10/13/17). "Press Release: Apeiron Strengthens Management Board with Industry Expert Peter Llewellyn-Davies as New Chief Financial Officer". Vienna. 2017-10-13
InflaRx GmbH. (10/13/17). "Press Release: InflaRx Announces a $ 55M Series D Financing and Investment Round to Foster Its Clinical Stage Complement anti-C5a Development Programs". Jena. 2017-10-13
EBD Group. (10/13/17). "Press Release: BIO-Europe 2017 to Bring 3,800 Life Science Leaders to Berlin November 6–8". Carlsbad, CA & Berlin. 2017-10-13
Roche. (10/13/17). "Press Release: CHMP Recommends EU Approval of Roche’s Alecensa (alectinib) as a First-line Treatment for People with ALK-positive NSCLC". Basel. 2017-10-13
CRISPR Therapeutics AG. (10/13/17). "Press Release: CRISPR Therapeutics Awarded Grant from Friedreich’s Ataxia Research Alliance to Collaborate with University of Alabama at Birmingham on Gene-edited Treatments for Friedrich’s Ataxia". Zug & Cambridge, M 2017-10-13
Genomics England Ltd.. (10/13/17). "Press Release: Genomics England Partners with Inivata and Thermo Fisher Scientific". 2017-10-13
Euronext N.V.. (10/13/17). "Press Release: Biom’up Lists on Euronext Paris to Finance Its Development". Paris. 2017-10-13
Oxford Nanopore Technologies Ltd.. (10/12/17). "Press Release: China Welcomes Oxford Nanopore Technology. Oxford Nanopore Sequencing Technology Is Now Available in China". 2017-10-12
Codexis Inc.. (10/12/17). "Press Release: Codexis and Nestlé Health Science Enter into Healthcare-focused Protein Engineering Platform Partnership". Redwood City, CA. 2017-10-12
Merck KGaA. (10/11/17). "Press Release: Merck Opens New Life Science Center for Scientific Collaboration". Darmstadt. 2017-10-11
Bryan, Garnier & Co., Ltd.. (10/11/17). "Press Release: Bryan Garnier & Co Acts as Sole Global Coordinator for Biom'Up's Landmark Euronext IPO, Raising up to €44 Million including Greenshoe". 2017-10-11
Evotec AG. (10/10/17). "Press Release: Evotec Achieves First Milestone in Neurodegeneration Alliance with Celgene". Hamburg. 2017-10-10
Bryan, Garnier & Co., Ltd.. (10/10/17). "Press Release: Bryan, Garnier & Co Grows Its Equity Research Healthcare Team". Paris. 2017-10-10
Qiagen N.V.. (10/9/17). "Press Release: Qiagen and Centogene to Collaborate in Bioinformatics for Genetic Diseases". Hilden, Rostock & Germantown, MD. 2017-10-09
Lonza Group AG. (10/9/17). "Press Release: Lonza Announces Formation of New Research and Development Collaborative Innovation Center in Israel". Basel. 2017-10-09
Bryan, Garnier & Co., Ltd.. (10/9/17). "Press Release: Bryan, Garnier & Co Grows Its Healthcare Franchise with the Hiring of Dr Anne Moore". Paris. 2017-10-09
Swedish Orphan Biovitrum AB. (10/6/17). "Press Release: Norbert Oppitz Joins Sobi as New Senior Vice President, Specialty Care". 2017-10-06
Cytel Inc.. (10/6/17). "Press Release: Cytel Adds New Basel Location In Continued Expansion". 2017-10-06
UK Government (Office for Life Sciences). (10/6/17). "Press Release: Office for Life Sciences Appoints New Director". 2017-10-06
Roche. (10/6/17). "Press Release: FDA Approves Roche cobas Zika as First Commercially-available Donor Screening Test for Zika virus". Basel. 2017-10-06
Uniqure N.V.. (10/6/17). "Press Release: uniQure Announces FDA Orphan Drug Designation for AMT-130 in Huntington’s Disease". Lexington, MA & Amsterdam. 2017-10-06
Tecan Group Ltd.. (10/6/17). "Press Release: Tecan Initiates Succession Process for the Board of Directors". Männedorf. 2017-10-06
Erytech Pharma. (10/6/17). "Press Release: Erytech Files Registration Statement for Proposed Initial Public Offering in the United States". Lyon. 2017-10-06
Bruker Corporation. (10/6/17). "Press Release: Bruker Introduces Additional Key Products for Diagnosis and Susceptibility Testing of Invasive Fungal Diseases (IFD) into European Clinical Microbiology Markets". Belgrade. 2017-10-06
Brooks Automation, Inc.. (10/5/17). "Press Release: Brooks Automation Acquires Life Sciences Consumables Provider 4titude, Ltd. and Secures $200 Million Term Loan". Chelmsford, MA. 2017-10-05
Progen Biotechnik GmbH. (10/5/17). "Press Release: Progen Acquires EuroProxima’s Research Antibodies". Heidelberg. 2017-10-05
Lonza Group Ltd.. (10/5/17). "Press Release: Lonza Cell & Gene Therapy Manufacturing Facility in Houston, TX, Area to Complete Construction on Schedule in 2017". Basel. 2017-10-05
Berlin Institute of Health. (10/5/17). "Press Release: Digital Health Accelerator from Berlin Health Innovations Starts with Three Teams". 2017-10-05
Cell and Gene Therapy Catapult, The. (10/5/17). "Press Release: iPSC Line Licensed to Universal Cells to Assist in the Development of Universal Donor Cell line". 2017-10-05
Desktop Genetics Ltd.. (10/4/17). "Press Release: Desktop Genetics Opens £1.5 Million Investment to Support Growth". London. 2017-10-04
Immunocore Ltd.. (10/4/17). "Press Release: Immunocore Appoints Andrew Hotchkiss as Chief Commercial Officer". Oxford & Conshohocken, PA. 2017-10-04
Immatics Biotechnologies GmbH. (10/4/17). "Press Release: Immatics Receives USD 58 Million in Financing to Develop T-Cell Receptor Based Immunotherapies". Tübingen & Houston, TX. 2017-10-04
Berlin Institute of Health. (10/4/17). "Press Release: BIH, Charité and MDC Sign Cooperation Agreement with Sanofi in Germany". 2017-10-04
Precision for Medicine. (10/4/17). "Press Release: Precision for Medicine Acquires Epiontis – a Leading Immune Monitoring and Epigenetic Technology Service Provider". Bethesda, MD & Berlin. 2017-10-04
Cell and Gene Therapy Catapult, The. (10/4/17). "Press Release: Innovate UK Announce Funding to Establish Network of Advanced Therapies Treatment Centres in the UK". 2017-10-04
Celyad S.A.. (10/3/17). "Press Release: Celyad Reports a First Complete Response in a Relapsed Refractory AML Patient in the THINK Trial". Mont-Saint-Guibert. 2017-10-03
Cell and Gene Therapy Catapult, The. (10/3/17). "Press Release: Cell and Gene Therapy Catapult Enters into Partnership with Forum for Innovative Regenerative Medicine". 2017-10-03
Merck KGaA. (10/3/17). "Press Release: Merck Invests € 35 Million in Its Italian Biotech Manufacturing Site of Bari". Bari. 2017-10-03
Noxxon Pharma N.V.. (10/3/17). "Press Release: Noxxon Publishes Preclinical Proof-of-Concept Data for Lead Compound NOX-A12 in Combination with Checkpoint Inhibitors". Berlin. 2017-10-03
Global Bioenergies S.A.. (10/3/17). "Press Release: Global Bioenergies Strengthens Its Management Team". Évry. 2017-10-03
Lonza Group Ltd.. (10/3/17). "Press Release: Lonza to Acquire a U.S. Clinical Manufacturing Site to Support Ongoing Customer Demand". Basel. 2017-10-03
Oryzon Genomics S.A.. (10/3/17). "Press Release: Significant Fact [Company Moves Registered Address from Barcelona to Madrid]". Madrid. 2017-10-03
Roche. (10/3/17). "Press Release: Roche Launches Navify Tumor Board Solution to Provide Decision Support to Oncology Care Teams". Basel. 2017-10-03
NuCana plc. (10/2/17). "Press Release: NuCana plc Announces Closing of Initial Public Offering of ADSs and Exercise of Underwriters’ Option to Purchase Additional ADSs". Edinburgh. 2017-10-02
Bruker Corporation. (10/2/17). "Press Release: Bruker Launches the Alpha II, the Second Generation of the World’s Most Popular Compact FTIR System for Chemical Analysis, Applied Markets and Industrial Quality Control". Billerica, MA. 2017-10-02
Ablynx N.V.. (10/2/17). "Press Release: Ablynx Files Registration Statement for a Proposed Global Offering". Ghent. 2017-10-02
Ablynx N.V.. (10/2/17). "Press Release: Ablynx Announces Positive Topline Results from the Phase III HERCULES Study of Caplacizumab for the Treatment of Acquired TTP". Ghent. 2017-10-02
Cell and Gene Therapy Catapult, The. (10/2/17). "Press Release: Cell and Gene Therapy Catapult Supporting Leading South Korean Biopharmaceutical Company". 2017-10-02
CRISPR Therapeutics AG. (10/2/17). "Press Release: CRISPR Therapeutics Announces Promotion of Samarth Kulkarni, Ph.D. to Chief Executive Officer". Zug & Cambridge, MA. 2017-10-02
Global Bioenergies S.A.. (10/2/17). "Press Release: Publication of the half-year results to 30/06/2017. Net Loss for the Group of €7.8 Million in the First Half of 2017". Évry. 2017-10-02
Pieris Pharmaceuticals, Inc.. (10/2/17). "Press Release: Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Trial for Fully Proprietary Lead IO Program, PRS-343". Boston, MA. 2017-10-02
Qiagen N.V.. (10/2/17). "Press Release: Qiagen Achieves ISO Certification for State-of-the-Art Quality in Forensics". Hilden & Germantown, MD. 2017-10-02
Transgene S.A.. (10/2/17). "Press Release: Transgene and Randox Sign Collaboration to Develop Innovative Multifunctional Oncolytic Virotherapies for Solid Tumors". Strasbourg & Belfast. 2017-10-02
Roche. (9/29/17). "Press Release: FDA Grants Priority Review for Roche’s Perjeta (pertuzumab) for Adjuvant Treatment of HER2-positive Early Breast Cancer". Basel. 2017-09-29
Noxxon Pharma N.V.. (9/29/17). "Press Release: Noxxon Supervisory Board Elects Experienced US & EU Biotech Veteran Don deBethizy Chairman". Berlin. 2017-09-29
Novartis AG. (9/28/17). "Press Release: Novartis and UC Berkeley Collaborate to Tackle »Undruggable« Disease Targets". Basel. 2017-09-28
Evotec AG. (9/28/17). "Press Release: Evotec Invests in Exscientia to Advance AI-driven Drug Discovery". Hamburg & Dundee. 2017-09-28
Allergy Therapeutics plc. (9/28/17). "Press Release: Preliminary Results". 2017-09-28
Immatics Biotechnologies GmbH. (9/28/17). "Press Release: Immatics Initiates the First Phase I Clinical Trial of its Unique ACTengine Approach in Patients with Advanced Solid Cancers". Houston, TX & Tübingen. 2017-09-28
Streck, Inc.. (9/28/17). "Press Release: Streck Signs Distribution Agreement with Orgentec SASU". La Vista, NE. 2017-09-28
NuCana plc. (9/28/17). "Press Release: NuCana plc Announces Pricing of Initial Public Offering". Edinburgh. 2017-09-28
Roche. (9/28/17). "Press Release: Roche’s Ocrevus (ocrelizumab) Approved in Switzerland for Primary Progressive and Relapsing Forms of Multiple Sclerosis". Basel. 2017-09-28
ThromboGenics N.V.. (9/28/17). "Press Release: ThromboGenics Successfully Introduces New »Already-Diluted« Formulation of Jetrea (ocriplasmin) in the US". Leuven. 2017-09-28
Basilea Pharmaceutica Ltd.. (9/28/17). "Press Release: Basilea Announces License Agreement for Antibiotic Zevtera (ceftobiprole) with Shenzhen China Resources Gosun Pharmaceutical Co., Ltd.". Basel. 2017-09-28
TATAA Biocenter AB. (9/28/17). "Press Release: TATAA Biocenter Expands Its Real-time PCR Offerings with the Mic from Bio Molecular Systems". Gothenburg & Upper Coomera. 2017-09-28
Noxxon Pharma N.V.. (9/28/17). "Press Release: Noxxon Provides Update on Ongoing Phase 1/2 Clinical Trial with Lead Program NOX-A12". Berlin. 2017-09-28
Abivax S.A.. (9/28/17). "Press Release: Abivax’s ABX464 Reduces HIV Reservoir in Blood in Second Phase 2a Clinical Trial". Paris. 2017-09-28
Crown Bioscience, Inc.. (9/27/17). "Press Release: Crown Bioscience Names Laurie Heilmann Chief Business Officer Executive Leader Brings Expertise in Global Strategy and Commercial Leadership to the Role". Santa Clara, CA. 2017-09-27
Alcobra Ltd.. (9/27/17). "Press Release: Alcobra Ltd. and Arcturus Therapeutics, Inc. Agree to Merge". Tel Aviv & San Diego, CA. 2017-09-27
Kiadis Pharma N.V.. (9/27/17). "Press Release: Kiadis Pharma Provides Update on the Marketing Authorization Application Process for ATIR101 in Europe". Amsterdam-Duivendrecht. 2017-09-27
Genedata AG. (9/27/17). "Press Release: Genedata Screener Strengthens Collaborative Research at Axxam". Basel. 2017-09-27
Endress+Hauser AG. (9/27/17). "Press Release: Endress+Hauser Inaugurates New Campus in Lyon". 2017-09-27
Oxford Immunotec Global plc. (9/27/17). "Press Release: Oxford Immunotec Announces Update in Patent Infringement Litigation". Oxford & Marlborough, MA. 2017-09-27
Ascendis Pharma A/S. (9/27/17). "Press Release: Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs". Copenhagen. 2017-09-27
Bruker Corporation. (9/26/17). "Press Release: Bruker Announces Acquisition of Merlin to Add Selected Antibiotic Resistance and Susceptibility Testing to its MALDI Biotyper Microbial Identification Platform". Bremen. 2017-09-26
Juno Therapeutics, Inc.. (9/26/17). "Press Release: Juno Therapeutics Closes Follow-on Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares". Seattle, WA. 2017-09-26
Eligo Bioscience. (9/26/17). "Press Release: Eligo Bioscience Secures $20 Million Series A from Khosla Ventures and Seventure to Bring Precision Medicine to the Microbiome". London. 2017-09-26
Autolus Ltd.. (9/26/17). "Press Release: Autolus Secures US$80 Million Series C Funding". London. 2017-09-26
Roivant Sciences GmbH. (9/26/17). "Press Release: Axovant Announces Negative Topline Results of Intepirdine Phase 3 MINDSET Trial in Alzheimer’s Disease". Basel. 2017-09-26
Editas Medicine, Inc.. (9/26/17). "Press Release: Editas Medicine Receives EMA’s Orphan Medicinal Product Designation for EDIT-101 for the Treatment of LCA10". Cambridge, MA. 2017-09-26
Janssen-Cilag International N.V.. (9/26/17). "Press Release: European Commission Approves Symtuza for the Treatment of HIV-1 In Adults and Adolescents in Europe". Beerse. 2017-09-26
Ascendis Pharma A/S. (9/26/17). "Press Release: Ascendis Pharma A/S Announces Dosing of Subjects in Phase 1 Trial of TransCon PTH". Copenhagen. 2017-09-26
Bryan, Garnier & Co., Ltd.. (9/26/17). "Press Release: Wilson and Waanders Join London Healthcare Franchise as Managing Directors". London. 2017-09-26
Microsaic Systems plc. (9/25/17). "Press Release: Appointment of Chief Executive Officer". 2017-09-25
Bone Therapeutics S.A.. (9/22/17). "Press Release: Bone Therapeutics and Asahi Kasei Sign Exclusive License Agreement for PREOB in Japan". Gosselies. 2017-09-22
Novartis AG. (9/22/17). "Press Release: Novartis and The Max Foundation Transform Pioneering Cancer Access Program for People in Lower-income Countries". Basel. 2017-09-22
Juno Therapeutics, Inc.. (9/21/17). "Press Release: Juno Therapeutics Prices $250 Million Follow-on Offering". Seattle, WA. 2017-09-21
Juno Therapeutics, Inc.. (9/21/17). "Press Release: Juno Therapeutics Opens New Headquarters and Research Center". Seattle, WA. 2017-09-21
Bavarian Nordic A/S. (9/21/17). "Press Release: Bavarian Nordic Provides Update on Its Universal RSV Vaccine". Copenhagen. 2017-09-21
Transgene S.A.. (9/21/17). "Press Release: Transgene Launches Invir.IO, its Integrated Platform for the Next Generation of Multifunctional Oncolytic Viruses". Strasbourg. 2017-09-21
Bone Therapeutics S.A.. (9/20/17). "Press Release: Bone Therapeutics Announces All Patients Meet Primary Endpoint in ALLOB® Phase I/IIA Delayed-union Study Interim Analysis". Gosselies. 2017-09-20
Abivax S.A.. (9/20/17). "Press Release: Abivax First-half 2017 Financial Results and Update". Paris. 2017-09-20
Abivax S.A.. (9/20/17). "Press Release: Abivax Receives French Regulatory Approval to Begin Clinical Trial of ABX464 in Ulcerative Colitis". Paris. 2017-09-20
Enterome S.A.. (9/20/17). "Press Release: Enterome to Move its Research Laboratories to Genopole, France’s First Biocluster". Évry. 2017-09-20
Roivant Sciences GmbH. (9/20/17). "Press Release: Roivant Sciences Launches Datavant to Improve Clinical Trials with Artificial Intelligence". San Francisco, CA & Basel. 2017-09-20
Novartis AG. (9/20/17). "Press Release: Novartis Drug Rydapt (midostaurin) Receives EU Approval for Newly Diagnosed FLT3-mutated Acute Myeloid Leukemia (AML) and Three Types of Advanced Systemic Mastocytosis (SM)". Basel. 2017-09-20
Abzena plc. (9/19/17). "Press Release: Abzena Appoints Lotta Ljungqvist as Non-Executive Director". Cambridge. 2017-09-19
1 2 3 ... 70 71 72  next pagenext page



Advertisement

Picture [LSF] Life-Sciences-France.com – The Business Web Portal 600x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px